The National Institutes of Health has recognized the need for and established a standard THC unit for research. Read the full notice at NIH.gov.
Prevalence of Substance Use Disorders by Time Since First Substance Use Among Young People in the US
The authors examined the prevalence of Substance Use Disorder (SUD) since first drug use (tobacco, alcohol, cannabis, cocaine, methamphetamine, and heroin) and prescription drug misuse
Young-adult compared to adolescent onset of regular cannabis use: A 20-year prospective cohort study of later consequences
This study followed nearly 1800 adolescents and young adults from age 15 to 35. Of that group, those who began using cannabis as adolescents were
Youth with pre-existing mood disorders who also have cannabis use disorder (CUD) were found to have an increased risk of self-harm, suicide, and death by
In studying the effects of THC-dominant, THC/CBD-equivalent, and CBD-dominant cannabis on driving performance, it was found that there was little difference between THC-dominant and the
Use of Genetically Informed Methods to Clarify the Nature of the Association Between Cannabis Use and Risk for Schizophrenia
This study, along with previous models, shows we still need further research on the correlation between cannabis use and schizophrenia. by Nathan A. Gillespie, PhD;
This study focuses on cannabis users, aged 16-65 years, recruited from Canada and the US, from areas that had and had not legalized non-medical cannabis.
This study shows that there is a distinction between an inherited predisposition to cannabis use and cannabis use disorder (CUD). This report also presents evidence
This review summarizes evidence on the effects of cannabis use on the development of adolescents and young adults. The acute risks include psychiatric symptoms associated
This study, following students into young adulthood, shows that vaping nicotine and cannabis have similar increasing trajectories. This shows that just as policies have been
As part of the “Adolescent Brain Cognitive Development” study to evaluate the children’s cognitive and behavior patterns at age 9 to 11 years, the authors
A study of students in grades 9-12 in Canada shows that students who reported medicinal cannabis use (MCU) were found to be at higher risk